{"id":"https://openalex.org/W3000720396","doi":"https://doi.org/10.1016/s0923-7534(20)33029-5","title":"The Clinical Utility of a Change in the Royal Marsden Hospital Prognostic Score (RMHPS) in Patients (PTS) Prior to Phase I Clinical Trial Therapy","display_name":"The Clinical Utility of a Change in the Royal Marsden Hospital Prognostic Score (RMHPS) in Patients (PTS) Prior to Phase I Clinical Trial Therapy","publication_year":2012,"publication_date":"2012-09-01","ids":{"openalex":"https://openalex.org/W3000720396","doi":"https://doi.org/10.1016/s0923-7534(20)33029-5","mag":"3000720396"},"language":"en","primary_location":{"id":"doi:10.1016/s0923-7534(20)33029-5","doi":"https://doi.org/10.1016/s0923-7534(20)33029-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(20)33029-5","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/s0923-7534(20)33029-5","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037375613","display_name":"Caroline Ogilvie Michie","orcid":"https://orcid.org/0000-0001-9198-0224","observed_orcids":["https://orcid.org/0000-0001-9198-0224"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C.O. Michie","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037530844","display_name":"Michael Ong","orcid":"https://orcid.org/0000-0002-0347-5541","observed_orcids":["https://orcid.org/0000-0002-0347-5541"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Ong","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037380661","display_name":"Joaqu\u0131\u0301n Mateo","orcid":"https://orcid.org/0000-0001-5336-2548","observed_orcids":["https://orcid.org/0000-0001-5336-2548"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Mateo","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015372750","display_name":"A.M. Young","orcid":"https://orcid.org/0009-0009-9427-4697","observed_orcids":["https://orcid.org/0009-0009-9427-4697"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A.M. Young","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072116005","display_name":"David Olmos","orcid":"https://orcid.org/0000-0002-7003-4826","observed_orcids":["https://orcid.org/0000-0002-7003-4826"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Olmos","raw_affiliation_strings":["DDU/Prostate Unit, Royal Marsden HospitalNHS Foundation Trust, Sutton, UNITED KINGDOM"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DDU/Prostate Unit, Royal Marsden HospitalNHS Foundation Trust, Sutton, UNITED KINGDOM","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032749624","display_name":"Joo Ern Ang","orcid":"https://orcid.org/0000-0003-2103-996X","observed_orcids":["https://orcid.org/0000-0003-2103-996X"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J.E. Ang","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013897432","display_name":"L. Rhoda Molife","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L.R. Molife","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032401979","display_name":"Udai Banerji","orcid":"https://orcid.org/0000-0003-1503-3123","observed_orcids":["https://orcid.org/0000-0003-1503-3123"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"U. Banerji","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J.S. de Bono","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109068159","display_name":"Stanley B. Kaye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S.B. Kaye","raw_affiliation_strings":["Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35084822,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":null,"first_page":"ix162","last_page":"ix162"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.7103999853134155,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.7103999853134155,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.07590000331401825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.7879999876022339},{"id":"https://openalex.org/keywords/trial-withdrawal","display_name":"trial withdrawal","score":0.7390000224113464},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8679999709129333},{"id":"https://openalex.org/keywords/short-term-outcome-prediction","display_name":"short-term outcome prediction","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.958694338798523},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4920344054698944},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4438871443271637},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.369131863117218}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0923-7534(20)33029-5","doi":"https://doi.org/10.1016/s0923-7534(20)33029-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(20)33029-5","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/s0923-7534(20)33029-5","doi":"https://doi.org/10.1016/s0923-7534(20)33029-5","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0923-7534(20)33029-5","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2763323264","https://openalex.org/W2588135157","https://openalex.org/W2060569900","https://openalex.org/W2080682920","https://openalex.org/W2590784817","https://openalex.org/W2598014680","https://openalex.org/W2590498907","https://openalex.org/W2607340630","https://openalex.org/W4321071344","https://openalex.org/W2769549211"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2020-01-23T00:00:00"}